PureHoney Technologies

PureHoney Technologies is a contract research organization (CRO) specializing in high-throughput screening (HTS) and mass spectrometry-based drug discovery services. The company leverages its proprietary expertise in label-free assay development and the Agilent RapidFire MS platform to provide rapid, high-quality screening for challenging biochemical and cell-based targets. Their services include lead discovery, metabolic stability testing, and custom assay development for pharmaceutical and biotechnology partners. In January 2024, PureHoney was acquired by Charles River Laboratories to bolster its early-stage discovery portfolio. The team consists of industry veterans who were instrumental in the original development of high-throughput mass spectrometry technologies.